Back to ENTA
Janus Henderson Group Ltd. → ENTA
Janus Henderson Group Ltd. ENTA Position History
Enanta Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$48.2M
Q3 2026
Peak value
$58.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $58.8M |
| Q1 2026 | $47.7M |
| Q1 2026 | $47.7M |
| Q3 2026 | $48.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $48.2M | 3.65M | — | — |
| Q1 2026 | $47.7M | 3.78M | — | — |
| Q1 2026 | $47.7M | 3.78M | — | — |
| Q4 2025 | $58.8M | 3.73M | — | — |